Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23788177 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1TDP1 | |
| SCHEMBL16116610 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1TDP1 | |
| SCHEMBL5531493 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1TDP1 | |
| SCHEMBL20174107 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1TDP1 | |
| SCHEMBL5201267 | 0.82 | ALDH1A1 (0.39) | ALDH1A1TSHRMAPK1TDP1 | |
| Ammonia Solution, Strong SCHEMBL1467329 | 0.80 | — | — | |
| SCHEMBL7871131 | 0.76 | — | — | |
| SCHEMBL7924495 | 0.74 | ALDH1A1 (0.36) | ALDH1A1TSHRMAPK1TDP1 | |
| SCHEMBL9841402 | 0.72 | — | — | |
| SCHEMBL7109936 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140179936-A1 | EPOXIDATION OF GLYCEROL AND DERIVATIVES THEREFROM | AEL MINING SERVICES LIMITED (ZA) | 2014-06-26 | — | — | US | disclosed |
| US-20140179936-A1 | EPOXIDATION OF GLYCEROL AND DERIVATIVES THEREFROM | AEL MINING SERVICES LIMITED (ZA) | 2014-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179936-A1 | EPOXIDATION OF GLYCEROL AND DERIVATIVES THEREFROM | GK, UGCG, GYPA | ALDH1A1 450/4885TSHR 3174/4885MAPK1 3711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.